Advanced Oncotherapy Management

Management criteria checks 2/4

Advanced Oncotherapy's CEO is Nicolas Serandour, appointed in Oct 2016, has a tenure of 7.08 years. directly owns 0.4% of the company’s shares, worth £38.10K. The average tenure of the management team and the board of directors is 8.3 years and 8.6 years respectively.

Key information

Nicolas Serandour

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.1yrs
CEO ownership0.4%
Management average tenure8.3yrs
Board average tenure8.6yrs

Recent management updates

How Much Are Advanced Oncotherapy plc (LON:AVO) Insiders Spending On Buying Shares?

Dec 13
How Much Are Advanced Oncotherapy plc (LON:AVO) Insiders Spending On Buying Shares?

Recent updates

Is Advanced Oncotherapy plc (LON:AVO) Potentially Undervalued?

Sep 10
Is Advanced Oncotherapy plc (LON:AVO) Potentially Undervalued?

How Much Are Advanced Oncotherapy plc (LON:AVO) Insiders Spending On Buying Shares?

Dec 13
How Much Are Advanced Oncotherapy plc (LON:AVO) Insiders Spending On Buying Shares?

CEO Compensation Analysis

How has Nicolas Serandour's remuneration changed compared to Advanced Oncotherapy's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

-UK£33m

Mar 31 2022n/an/a

-UK£31m

Dec 31 2021UK£503kUK£300k

-UK£29m

Sep 30 2021n/an/a

-UK£28m

Jun 30 2021n/an/a

-UK£26m

Mar 31 2021n/an/a

-UK£26m

Dec 31 2020UK£336kUK£300k

-UK£25m

Sep 30 2020n/an/a

-UK£24m

Jun 30 2020n/an/a

-UK£22m

Mar 31 2020n/an/a

-UK£21m

Dec 31 2019UK£401kUK£247k

-UK£21m

Sep 30 2019n/an/a

-UK£21m

Jun 30 2019n/an/a

-UK£21m

Mar 31 2019n/an/a

-UK£21m

Dec 31 2018UK£1mUK£233k

-UK£21m

Jun 30 2018n/an/a

-UK£18m

Mar 31 2018n/an/a

-UK£16m

Dec 31 2017UK£239kUK£215k

-UK£14m

Jun 30 2017n/an/a

-UK£12m

Mar 31 2017n/an/a

-UK£11m

Dec 31 2016UK£208kUK£180k

-UK£10m

Compensation vs Market: Insufficient data to establish whether Nicolas's total compensation is reasonable compared to companies of similar size in the UK market.

Compensation vs Earnings: Nicolas's compensation has increased whilst the company is unprofitable.


CEO

Nicolas Serandour (48 yo)

7.1yrs

Tenure

UK£502,965

Compensation

Mr. Nicolas Serandour has been the Chief Executive Officer of Advanced Oncotherapy Plc since October 27, 2016. Mr. Serandour served as the Chief Financial Officer and Chief Operating Officer at Advanced On...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Sinclair
Executive Chairman17.4yrsUK£434.42k1.74%
£ 165.2k
Nicolas Serandour
CEO & Executive Director7.1yrsUK£502.97k0.40%
£ 38.1k
Stephen Myers
Executive Directorno dataUK£397.72k0.28%
£ 27.0k
Ed Lee
COO & President of Europe6.4yrsno datano data
Graham Pughe
Senior Vice-President of Accounting10.9yrsno datano data
Berengere Pons-Chabord
Senior Vice-President of Corporate Financeno datano datano data
Manuel Gallas
Director of Technical & Engineeringno datano datano data
David Navas
Vice President of Investor and Public Relations6.9yrsno datano data
Bridget Biggar
Director of Human Resources7yrsno datano data
Donatella Ungaro
Managing Director of ADAM15.4yrsno datano data
Marina Giunta
Head of Physics Group10.2yrsno datano data
Giovanni De Michele
Head of Radiofrequency Group9.6yrsno datano data

8.3yrs

Average Tenure

76yo

Average Age

Experienced Management: AVO's management team is seasoned and experienced (8.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Sinclair
Executive Chairman17.4yrsUK£434.42k1.74%
£ 165.2k
Nicolas Serandour
CEO & Executive Director9.3yrsUK£502.97k0.40%
£ 38.1k
Stephen Myers
Executive Director8yrsUK£397.72k0.28%
£ 27.0k
Euan Thomson
Member of Medical Advisory Board5.8yrsUK£15.00kno data
Hans von Celsing
Senior Independent Director6.8yrsUK£67.50k0.18%
£ 17.2k
Jay Loeffler
Member of Medical Advisory Board10.1yrsno datano data
Enrico Vanni
Independent Non-Executive Director10.1yrsUK£62.50k0.75%
£ 71.3k
Ugo Amaldi
Member of Medical Advisory Boardno datano datano data
Michael Bradfield
Independent Non-Executive Director10.6yrsUK£50.00k1.54%
£ 146.2k
Piers Plowman
Independent Chairman of Medical Advisory Board & Non-Executive Director6.8yrsUK£40.00k0.86%
£ 81.8k
Margaret Spittle
Member of Medical Advisory Boardno datano datano data
Renhua Zhang
Independent Non-Executive Director5.3yrsUK£30.00kno data

8.6yrs

Average Tenure

73yo

Average Age

Experienced Board: AVO's board of directors are considered experienced (8.6 years average tenure).